Patents by Inventor Raymond Ferri
Raymond Ferri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8650184Abstract: A method. The method includes receiving, at a computing device, data associated with a first plurality of consumers. The data comprises a combination of behavioral data and attitudinal data. The method also includes assigning a consumer of the first plurality of consumers to a first respective segments based on the received data, wherein the assigning is performed by the computing device. The method further includes calculating a goodness-of-fit score for the consumer of the first plurality of consumers for the first segment, wherein the calculating is performed by the computing device. Additionally, the method includes calculating a predicted goodness-of-fit score for a consumer of a second plurality of consumers for the first segment, the second plurality of consumers including at least the first plurality of consumers, wherein the calculating is performed by the computing device.Type: GrantFiled: February 4, 2011Date of Patent: February 11, 2014Assignee: Twenty-Ten, Inc.Inventors: Craig Kowalchuk, Sheldon Smith, David Diamond, Raymond Ferris
-
Publication number: 20130132101Abstract: A system. The system includes a computing device and a combiner module. The computing device includes a processor. The combiner module is communicably connected to the processor, and is configured to combine a score generated by a behavioral targeting model with a score generated by an attitudinal targeting model.Type: ApplicationFiled: November 17, 2011Publication date: May 23, 2013Applicant: Twenty-Ten, Inc.Inventors: Craig W. Kowalchuck, Sheldon H. Smith, David Diamond, Raymond Ferris
-
Publication number: 20120203780Abstract: A method. The method includes receiving, at a computing device, data associated with a first plurality of consumers. The data comprises a combination of behavioral data and attitudinal data. The method also includes assigning a consumer of the first plurality of consumers to a first respective segments based on the received data, wherein the assigning is performed by the computing device. The method further includes calculating a goodness-of-fit score for the consumer of the first plurality of consumers for the first segment, wherein the calculating is performed by the computing device. Additionally, the method includes calculating a predicted goodness-of-fit score for a consumer of a second plurality of consumers for the first segment, the second plurality of consumers including at least the first plurality of consumers, wherein the calculating is performed by the computing device.Type: ApplicationFiled: February 4, 2011Publication date: August 9, 2012Applicant: Twenty-Ten, Inc.Inventors: Craig Kowalchuck, Sheldon Smith, David Diamond, Raymond Ferris
-
Publication number: 20100130405Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.Type: ApplicationFiled: July 6, 2009Publication date: May 27, 2010Applicant: Brown Technology PartnershipsInventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Raymond Ferri, Alison Amenta, Mary Lynn Mercado, Hiroki Hagiwara
-
Publication number: 20080274966Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.Type: ApplicationFiled: February 22, 2008Publication date: November 6, 2008Applicant: Brown University Research FoundationInventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Raymond Ferri
-
Patent number: 7335637Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.Type: GrantFiled: June 14, 2004Date of Patent: February 26, 2008Assignee: Brown University Research FoundationInventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Raymond Ferri
-
Publication number: 20050059580Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.Type: ApplicationFiled: June 14, 2004Publication date: March 17, 2005Applicant: Brown University Research FoundationInventors: Justin Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark Bowe, Raymond Ferri
-
Patent number: 6864236Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.Type: GrantFiled: November 17, 2000Date of Patent: March 8, 2005Assignee: Brown University Research FoundationInventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Raymond Ferri
-
Publication number: 20040063627Abstract: The invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Example of diseases include muscular dystrophies, such as Duchenne's Muscular Dystrophy, Becker's Muscular Dystrophy, neuromuscular disorders and neurological disorders.Type: ApplicationFiled: February 20, 2002Publication date: April 1, 2004Inventors: Justin R. Fallon, Beth McKechnie, Michael Rafii, Hilliary Creely, Mark A. Bowe, Raymond Ferri